VINCRISTINE (NSC-67574) THERAPY OF ADULT PATIENTS WITH SOLID TUMORS.
D000230:Adenocarcinoma; D000970:Antineoplastic Agents; D002276:Carcinoid Tumor; D002283:Carcinoma, Bronchogenic; D002294:Carcinoma, Squamous Cell; D002295:Carcinoma, Transitional Cell; D005260:Female; D005472:Fluorouracil; D005706:Gallbladder Neoplasms; D006801:Humans; D008545:Melanoma; D009369:Neoplasms; D010190:Pancreatic Neoplasms; D012004:Rectal Neoplasms; D012811:Sigmoid Neoplasms; D013274:Stomach Neoplasms; D014116:Toxicology; D001749:Urinary Bladder Neoplasms; D002583:Uterine Cervical Neoplasms; D014750:Vincristine
D000970:Antineoplastic Agents; D014750:Vincristine; D005472:Fluorouracil
ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; BLADDER NEOPLASMS; CARCINOID TUMOR; CARCINOMA, BRONCHOGENIC; CARCINOMA, EPIDERMOID; CARCINOMA, TRANSITIONAL CELL; CERVIX NEOPLASMS; FLUOROURACIL; GALLBLADDER NEOPLASMS; MELANOMA; PANCREATIC NEOPLASMS; RECTAL NEOPLASMS; SIGMOID NEOPLASMS; STOMACH NEOPLASMS; TOXICOLOGIC REPORT; VINCRISTINE